Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Effect of pravastatin on coronary events in patients with coronary artery disease and a left ventricular ejection fraction (LVEF) of >0.40 enrolled in the Cholesterol And Recurrent Events trial (2). CHD = coronary heart disease. White bar = placebo; shaded bar = pravastatin.
|
